205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-51.02%
Negative revenue growth while AMD stands at 8.76%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-46.54%
Negative gross profit growth while AMD is at 19.36%. Joel Greenblatt would examine cost competitiveness or demand decline.
-9.60%
Negative EBIT growth while AMD is at 30.39%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-55.20%
Negative operating income growth while AMD is at 30.39%. Joel Greenblatt would press for urgent turnaround measures.
80.95%
Net income growth above 1.5x AMD's 44.62%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
81.13%
EPS growth at 75-90% of AMD's 100.00%. Bill Ackman would push for improved profitability or share repurchases to catch up.
81.13%
Diluted EPS growth at 75-90% of AMD's 100.00%. Bill Ackman would expect further improvements in net income or share count reduction.
0.19%
Share reduction more than 1.5x AMD's 7.84%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.19%
Diluted share reduction more than 1.5x AMD's 8.26%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-3.21%
Dividend reduction while AMD stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
316.99%
OCF growth under 50% of AMD's 672.25%. Michael Burry might suspect questionable revenue recognition or rising costs.
184.15%
FCF growth above 1.5x AMD's 107.96%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-28.67%
Negative 10Y revenue/share CAGR while AMD stands at 28.85%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-39.49%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-62.42%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
64.38%
Positive OCF/share growth while AMD is negative. John Neff might see a comparative advantage in operational cash viability.
39.55%
Positive 3Y OCF/share CAGR while AMD is negative. John Neff might see a big short-term edge in operational efficiency.
-185.06%
Negative 10Y net income/share CAGR while AMD is at 53.25%. Joel Greenblatt sees a major red flag in long-term profit erosion.
70.38%
Positive 5Y CAGR while AMD is negative. John Neff might view this as a strong mid-term relative advantage.
-115.93%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
91.70%
Equity/share CAGR of 91.70% while AMD is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
88.43%
5Y equity/share CAGR 1.25-1.5x AMD's 60.82%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
33.93%
Positive short-term equity growth while AMD is negative. John Neff sees a strong advantage in near-term net worth buildup.
1.01%
Dividend/share CAGR of 1.01% while AMD is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
19.89%
Stable or rising mid-term dividends while AMD is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
42.45%
Our short-term dividend growth is positive while AMD cut theirs. John Neff views it as a comparative advantage in shareholder returns.
-17.25%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-29.91%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-2.06%
Negative asset growth while AMD invests at 2.99%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.62%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
6.74%
Debt growth far above AMD's 0.22%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-55.80%
Our R&D shrinks while AMD invests at 1.74%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-10.69%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.